[Use of flunarizine in mild-to-severe senile cerebral deterioration].
Within the framework of multifactorial etiology the use of calcium entry blockers as a complementary measure in the management of moderate-to-severe senile brain deterioration has been studied. Clinical study of twelve flunarizine-treated patients has yielded promising evidence in favor of vasoactive drugs as adjuvants to treatment with psychoactive drugs. Further studies should lend support to this hypothesis.